DB19227InvestigationalProtein Based Therapies
Human growth hormone-releasing peptide 3 is under investigation in clinical trial NCT00846872 (Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance).
- Also known as
- L-argininamide, 2-methylalanyl-d-tryptophyl-d-prolyl-d-isoleucyl-
- Code names
- GHRP-3
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Human growth hormone-releasing peptide 3, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account